<?xml version="1.0" encoding="UTF-8"?>
<p>With insulin resistance being central in type 2 diabetes pathogenesis, a new alternative in the inhibition of DPP (IV) has proposed in order to stimulate the release of insulin. From the inhibitory activities of the extracts with DPP (IV), the results revealed that both of the extracts displayed a good inhibitory potential by having an increment in the percent of inhibition for the DPP (IV) enzyme.</p>
